Univest
Univest
  • Markets

SMS Pharmaceuticals (SMSPHARMA) Share Price Rises 8.06% to Rs 477.95 Today

  • September 7, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
SMS Pharmaceuticals Share Price
SMS Pharmaceuticals Ltd. (SMSPHARMA) share price rose to Rs 477.95 today, up 8.06% from the previous close. Market cap was Rs 3,906.23 crore.

The SMS Pharmaceuticals share price rose 8.06% today and traded at Rs 477.95 as of 2:52 PM IST on 28 October 2026, a gain of Rs 35.65 over the previous close of Rs 442.30. The pharmaceutical company is listed on NSE and BSE, and it carries a market capitalisation of Rs 3,906.23 crore. At the time of writing, the stock is trading at its day high of Rs 477.95.

Univest figures confirm the price action, but they do not point to a specific company trigger. What the latest Univest figures do show is a stock that opened at Rs 439.55, touched a low of Rs 439.50 and then climbed to its high, a clear price rise inside a single day. This SMS Pharmaceuticals stock news report walks through the price action, the fundamental analysis, the sector benchmark and the peer comparison, so that readers can follow the SMS Pharmaceuticals share price move with verified numbers.

Table of Contents

Toggle
  • SMS Pharmaceuticals Share Price Today: Price Action Analysis
  • SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching SMS Pharmaceuticals
  • About SMS Pharmaceuticals
  • Frequently Asked Questions
    • What is the SMS Pharmaceuticals share price today?
    • Why is the SMS Pharmaceuticals share price rising today?
    • What is the market capitalisation of SMS Pharmaceuticals?
    • What is the P/E ratio of SMS Pharmaceuticals compared with its industry?
    • What are the ROE and ROCE of SMS Pharmaceuticals?
    • What are the EPS, book value and dividend yield of SMS Pharmaceuticals?
    • How does SMS Pharmaceuticals compare with its listed peers?
    • What was the day range of the SMS Pharmaceuticals share price today?
  • Track SMS Pharmaceuticals Share Price on Univest

SMS Pharmaceuticals Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 477.95
Previous Close Rs 442.3
Today's Move Rs 35.65 (+8.06%)
Open Rs 439.55
High Rs 477.95
Low Rs 439.5
Market Capitalisation Rs 3,906.23 crore
Market Cap Category Small Cap

SMS Pharmaceuticals Ltd. (SMSPHARMA) rose to Rs 477.95 from the previous close of Rs 442.3, a move of Rs 35.65 or 8.06%. The stock opened at Rs 439.55, reached a high of Rs 477.95, recorded a low of Rs 439.5.

SMS Pharmaceuticals share price today stands at Rs 477.95, up Rs 35.65 or 8.06% from the previous close of Rs 442.30. The stock opened at Rs 439.55, touched a low of Rs 439.50 and has reached a high of Rs 477.95, which is also its latest traded level.

The opening price was Rs 2.75 below the previous close, so the stock started the day slightly lower. The day low of Rs 439.50 came just Rs 0.05 under the opening level, which means the SMS Pharmaceuticals share price found its floor almost immediately after the open.

From there, the share price climbed Rs 38.40 above the day open and now sits at the top of a day range that measures Rs 38.45 between the low and the high. The SMS Pharmaceuticals share price live reading therefore matches the day high, and this price action is the main fact that places the stock among the market movers on the Indian stock market today. The next section looks at the fundamental analysis behind the number.

SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 3,906.23 crore
P/E Ratio 40.45x
P/B Ratio 5.14x
ROE 12.49%
ROCE 13.32%
EPS Rs 10.93
Book Value Per Share Rs 86.06
Dividend Yield 0.09%

SMS Pharmaceuticals Ltd. (SMSPHARMA) fundamental metrics show P/E 40.45x, P/B 5.14x, ROE 12.49%, ROCE 13.32%. Taken on their own, these numbers offer context rather than a trading signal.

SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 3,906.23 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 40.45x, P/B at 5.14x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.49% and ROCE of 13.32%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.93, book value per share of Rs 86.06, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 40.45x
Benchmark Median P/E 30.74x
Benchmark Average P/E 43.3x
Benchmark P/E Range 3.21x to 577.05x
Company P/B Ratio 5.14x
Benchmark Median P/B 2.71x
Company ROE 12.49%
Benchmark Median ROE 11.23%
Company ROCE 13.32%
Benchmark Median ROCE 13.17%
Company Market Capitalisation Rs 3,906.23 crore
Benchmark Median Market Cap Rs 696.43 crore

SMS Pharmaceuticals Ltd. (SMSPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 40.45x, which is above the benchmark median of 30.74x, a difference of +31.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROE of 12.49%, which is above the benchmark median of 11.23%, a difference of +11.22%. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROCE of 13.32%, which is above the benchmark median of 13.17%, a difference of +1.14%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,18,204.09 34.91 4.88 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,40,780 86.02 14.25 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,73,828.11 82.48 9.53 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,15,520.92 25.79 4.32 19.69 21.39
Laurus Labs Ltd. LAURUSLABS 1,11,304.32 105.74 20.5 18.31 18.2

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 40.45x compared with the displayed peer median of 82.48x. The comparison is relative and should not be read as a recommendation. Its ROE of 12.49% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 13.32% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a market capitalisation of Rs 3,906.23 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching SMS Pharmaceuticals

  • Price action: the stock rose 8.06% to Rs 477.95 and is trading at its day high after opening at Rs 439.55.
  • Fundamentals: the company reports a P/E ratio of 40.45, EPS of Rs 10.93 and a book value of Rs 86.06 per share.
  • Returns: ROE of 12.49% and ROCE of 13.32% are both slightly above the industry median.
  • Sector position: the P/E is above the industry median of 30.74 but below the industry average of 43.30.
  • Peer position: the market capitalisation of Rs 3,906.23 crore is far below the large listed peers in the same industry.

About SMS Pharmaceuticals

SMS Pharmaceuticals Ltd. is a listed company in the Healthcare sector, operating in the Pharmaceuticals and Drugs industry, and its shares trade on NSE and BSE. With a market capitalisation of Rs 3,906.23 crore, it sits well above the median of its industry group but far below the largest pharmaceutical names. Investors who want deeper company information can use the company page on Univest.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the SMS Pharmaceuticals share price today?

Ans. The SMS Pharmaceuticals share price traded at Rs 477.95 as of 2:52 PM IST on 28 October 2026, up Rs 35.65 or 8.06% from the previous close of Rs 442.30, and it is at the day high.

Why is the SMS Pharmaceuticals share price rising today?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock opened at Rs 439.55, touched a low of Rs 439.50 and is now trading at its high of Rs 477.95.

What is the market capitalisation of SMS Pharmaceuticals?

Ans. The market capitalisation of SMS Pharmaceuticals is Rs 3,906.23 crore. This is above the industry median of Rs 696.43 crore and below the industry average of Rs 13,492.66 crore, based on a benchmark of 199 companies.

What is the P/E ratio of SMS Pharmaceuticals compared with its industry?

Ans. SMS Pharmaceuticals has a P/E ratio of 40.45. That is above the industry median of 30.74 and below the industry average of 43.30, according to the latest Univest figures for the same industry benchmark.

What are the ROE and ROCE of SMS Pharmaceuticals?

Ans. The return on equity of SMS Pharmaceuticals is 12.49% and the return on capital employed is 13.32%. Both are slightly above the industry medians of 11.23% and 13.17%, according to the latest Univest figures for the industry.

What are the EPS, book value and dividend yield of SMS Pharmaceuticals?

Ans. Earnings per share is Rs 10.93 and book value per share is Rs 86.06. The dividend yield is 0.09%, a historical figure relative to the current price, so it does not guarantee any future payout to shareholders.

How does SMS Pharmaceuticals compare with its listed peers?

Ans. The ROE of 12.49% and ROCE of 13.32% are below all five peers, and the P/E of 40.45 sits between Sun Pharmaceutical Industries at 34.91 and Torrent Pharmaceuticals at 82.48. The market capitalisation is also much smaller.

What was the day range of the SMS Pharmaceuticals share price today?

Ans. The SMS Pharmaceuticals share price opened at Rs 439.55, touched a low of Rs 439.50 and reached a high of Rs 477.95. The day range is Rs 38.45, and the latest traded price equals the day high.

Track SMS Pharmaceuticals Share Price on Univest

Use SMS Pharmaceuticals Ltd. (SMSPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track the live SMS Pharmaceuticals share price on Univest, along with fundamental ratios, 52-week levels and market insights for the stock. Univest also lists the sector benchmark and peer figures used in this report, so the SMS Pharmaceuticals share price update can be checked against fresh numbers. This is information only and not a recommendation.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply